Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events

Circulation: Cardiovascular Imaging

Volumn 6, Issue 6, 2013, Pages 864-872

  Park, Jae Hyeong ^a,b   Negishi, Kazuaki ^a   Grimm, Richard A ^a   Popovic, Zoran ^a   Stanton, Tony ^c   Wilkoff, Bruce L ^a   Marwick, Thomas H ^d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Chungnam National University   (South Korea)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Cardiac resynchronization therapy; Echocardiography; Heart failure; Ventricular remodeling

Indexed keywords

AGED; ARTICLE; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR PARAMETERS; CAUSE OF DEATH; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE OVERLOAD; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; HUMAN; IMPLANTATION; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY; HEART FAILURE; VENTRICULAR REMODELING;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 84892147479     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.112.000026     Document Type: Article

References (38)

1. Bristow MR, Saxon LA, Boehmer J, Krueger S., Kass DA, De Marco T, Carson P, DiCarlo L., DeMets D, White BG, DeVries D.W., Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004; 350:2140-2150.
2. Cleland JG, Daubert JC, Erdmann E, Freemantle N., Gras D, Kappenberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005; 352:1539-1549.
3. Abraham WT, Fisher WG, Smith A.L., Delurgio DB, Leon AR, Loh E, Kocovic D.Z., Packer M., Clavell AL, Hayes DL, Ellestad M, Trupp R.J., Underwood J., Pickering F, Truex C, McAtee P., Messenger J; MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002; 346:1845-1853.
4. Adabag S, Roukoz H, Anand I.S., Moss AJ Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis. J Am Coll Cardiol. 2011; 58:935-941.
5. Tang AS, Wells GA, Talajic M, Arnold M.O., Sheldon R., Connolly S, Hohnloser SH, Nichol G, Birnie D.H., Sapp JL, Yee R, Healey JS, Rouleau JL; Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010; 363:2385-2395.
6. Linde C, Abraham WT, Gold M.R., St John Sutton M, Ghio S, Daubert C; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008; 52:1834-1843.
7. Moss AJ, Hall WJ, Cannom D.S., Klein H., Brown MW, Daubert JP, Estes NA III, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W; MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009; 361:1329-1338.
8. Solomon SD, Foster E, Bourgoun M., Shah A, Viloria E, Brown M.W., Hall WJ, Pfeffer MA, Moss AJ; MADIT-CRT Investigators. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchroni-zation therapy. Circulation. 2010; 122:985-992.
9. Ypenburg C, van Bommel RJ, Borleffs CJ, Bleeker GB, Boersma E, Schalij M.J., Bax JJ Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol. 2009; 53:483-490.
10. Adelstein E, Schwartzman D, Gorcsan J III, Saba S. Predicting hyperresponse among pacemaker-dependent nonischemic cardiomyopathy patients upgraded to cardiac resynchronization. J Cardiovasc Electrophysiol. 2011; 22:905-911.
11. Kyriacou A, Pabari PA, Francis DP Cardiac resynchronization therapy is certainly cardiac therapy, but how much resynchronization and how much atrioventricular delay optimization? Heart Fail Rev. 2012; 17:727-736.
12. Goldenberg I, Moss AJ, Hall W.J., Foster E., Goldberger JJ, Santucci P, Shinn T, Solomon S., Steinberg JS, Wilber D, Barsheshet A, McNitt S., Zareba W, Klein H; MADIT-CRT Executive Committee. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011; 124:1527-1536.
13. Jamal F, Bergerot C, Argaud L., Loufouat J, Ovize M. Longitudinal strain quantitates regional right ventricular contractile function. Am J Physiol Heart Circ Physiol. 2003; 285:H2842-H2847.
14. Roes SD, Mollema SA, Lamb H.J., van der Wall EE, de Roos A, Bax JJ. Validation of echocardiographic two-dimensional speckle tracking longitudinal strain imaging for viability assessment in patients with chronic ischemic left ventricular dysfunction and comparison with contrast-enhanced magnetic resonance imaging. Am J Cardiol. 2009; 104:312-317.
15. Lang RM, Bierig M, Devereux R.B., Flachskampf FA, Foster E, Pellikka PA, Picard M.H., Roman MJ, Seward J, Shanewise JS, Solomon S.D., Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18:1440-1463.
16. Rudski LG, Lai WW, Afilalo J, Hua L., Handschumacher MD, Chandrasekaran K, Solomon SD, Louie E.K., Schiller NB Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010; 23:685-713; quiz 786.
17. Pirat B, McCulloch ML, Zoghbi WA Evaluation of global and regional right ventricular systolic function in patients with pulmonary hypertension using a novel speckle tracking method. Am J Cardiol. 2006; 98:699-704.
18. Hanley JA, McNeil BJ The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982; 143:29-36.
19. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008; 27:157-172; discussion 207.
20. Epstein AE, DiMarco JP, Ellenbogen K.A., Estes NA III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008; 117:e350-e408.
21. Cazeau S, Leclercq C, Lavergne T., Walker S, Varma C, Linde C., Garrigue S, Kappenberger L, Haywood G.A., Santini M., Bailleul C, Daubert JC; Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001; 344:873-880.
22. Cleland JG, Tageldien A, Buga L., Wong K, Gorcsan J III. Should we be trying to define responders to cardiac resynchronization therapy? JACC Cardiovasc Imaging. 2010; 3:541-549.
23. Bax JJ, Abraham T, Barold S.S., Breithardt OA, Fung JW, Garrigue S, Gorcsan J III, Hayes DL, Kass DA, Knuuti J, Leclercq C, Linde C, Mark DB, Monaghan MJ, Nihoyannopoulos P, Schalij MJ, Stellbrink C, Yu CM. Cardiac resynchronization therapy: Part 1-issues before device implantation. J Am Coll Cardiol. 2005; 46:2153-2167.
24. Yu CM, Bleeker GB, Fung J.W., Schalij MJ, Zhang Q, van der Wall EE, Chan YS, Kong SL, Bax JJ. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchro-nization therapy. Circulation. 2005; 112:1580-1586.
25. Yu CM, Fung JW, Zhang Q, Chan C.K., Chan YS, Lin H, Kum LC, Kong S.L., Zhang Y., Sanderson JE Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac re-synchronization therapy. Circulation. 2004; 110:66-73.
26. Bleeker GB, Bax JJ, Fung J.W., van der Wall EE, Zhang Q, Schalij MJ, Chan JY, Yu CM. Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am J Cardiol. 2006; 97:260-263.
27. Calvert MJ, Freemantle N, Yao G., Cleland JG, Billingham L, Daubert JC, Bryan S; CARE-HF investigators. Cost-effectiveness of cardiac re-synchronization therapy: results from the CARE-HF trial. Eur Heart J. 2005; 26:2681-2688.
28. Yao G, Freemantle N, Calvert M.J., Bryan S., Daubert JC, Cleland JG The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J. 2007; 28:42-51.
29. Marwick TH. Measurement of strain and strain rate by echocardiography: ready for prime time? J Am Coll Cardiol. 2006; 47:1313-1327.
30. Stanton T, Leano R, Marwick TH Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imaging. 2009; 2:356-364.
31. Rossi A, Cicoira M, Bonapace S., Golia G, Zanolla L, Franceschini L., Vassanelli C. Left atrial Volume provides independent and incremental information compared with exercise tolerance parameters in patients with heart failure and left ventricular systolic dysfunction. Heart. 2007; 93:1420-1425.
32. D'Andrea A., Scarafile R, Riegler L., Salerno G, Gravino R, Cocchia R., Castaldo F, Allocca F, Limongelli G., Di Salvo G, Cuomo S, Pacileo G., Caso P, Russo MG, Calabrò R. Right atrial size and deformation in patients with dilated cardiomyopathy undergoing cardiac resynchronization therapy. Eur J Heart Fail. 2009; 11:1169-1177.
33. de Groote P., Millaire A, Foucher-Hossein C, Nugue O., Marchandise X, Ducloux G, Lablanche JM Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol. 1998; 32:948-954.
34. Di Salvo T.G., Mathier M, Semigran M.J., Dec GW Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol. 1995; 25:1143-1153.
35. Juillière Y., Barbier G, Feldmann L., Grentzinger A, Danchin N, Cherrier F. Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. Eur Heart J. 1997; 18:276-280.
36. Burri H, Domenichini G, Sunthorn H., Fleury E, Stettler C, Foulkes I., Shah D. Right ventricular systolic function and cardiac resynchronization therapy. Europace. 2010; 12:389-394.
37. Alpendurada F, Guha K, Sharma R., Ismail TF, Clifford A, Banya W, Mohiaddin R.H., Pennell DJ, Cowie MR, McDonagh T, Prasad SK Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy. J Cardiovasc Magn Reson. 2011; 13:68.
38. Scuteri L, Rordorf R, Marsan N.A., Landolina M., Magrini G, Klersy C, Frattini F., Petracci B, Vicentini A, Campana C., Tavazzi L, Ghio S. Relevance of echocardiographic evaluation of right ventricular function in patients undergoing cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2009; 32:1040-1049.